Xtl Biopharmaceuticals (XTLB) Cash from Operations (2009 - 2016)
Xtl Biopharmaceuticals (XTLB) recorded Cash from Operations of -$1.03 million in the year ended Dec 31, 2025, compared with -$1.62 million a year earlier.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Cash from Operations (2009 - 2016) Analysis & Trends
Starting with the year ended Dec 31, 2009, Xtl Biopharmaceuticals' Cash from Operations history includes 17 years.
- Annual Cash from Operations has ranged from -$1.62 million in the year ended Dec 31, 2024 to -$707,000 in the year ended Dec 31, 2023 over the past five years.
- Per Business Quant data, XTLB's Cash from Operations was -$1.62 million in the year ended Dec 31, 2024, -$707,000 in the year ended Dec 31, 2023, -$901,000 in the year ended Dec 31, 2022 and -$1.05 million in the year ended Dec 31, 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,129.53 Bn | 1,098.12 Bn | 19.71 Bn | 10.69 Bn |
| 2 | Johnson & Johnson | 635.66 Bn | 555.53 Bn | 17.30 Bn | 7.72 Bn |
| 3 | AbbVie | 504.81 Bn | 477.92 Bn | 12.70 Bn | 3.44 Bn |
| 4 | Merck | 358.21 Bn | 312.59 Bn | 12.21 Bn | 5.37 Bn |
| 5 | Novartis Ag | 290.21 Bn | 254.20 Bn | 11.24 Bn | 5.88 Bn |
| 6 | Astrazeneca | 264.86 Bn | 238.55 Bn | 12.86 Bn | 2.87 Bn |
| 7 | Amgen | 237.58 Bn | 192.98 Bn | 7.24 Bn | 4.00 Bn |
| 8 | Gilead Sciences | 194.88 Bn | 169.08 Bn | 6.22 Bn | 3.57 Bn |
| 9 | Pfizer | 171.14 Bn | 117.79 Bn | 10.94 Bn | 835.00 Mn |
| 10 | Xtl Biopharmaceuticals | 17.65 Mn | 14.46 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2016 | -508,000.00 |
| Dec 31, 2015 | -498,000.00 |
| Sep 30, 2015 | -438,000.00 |
| Jun 30, 2015 | -514,000.00 |
| Dec 31, 2014 | -674,000.00 |
| Sep 30, 2014 | -455,000.00 |
| Jun 30, 2014 | -544,000.00 |
| Mar 31, 2014 | -797,000.00 |
| Dec 31, 2013 | -520,000.00 |
| Sep 30, 2013 | -758,000.00 |
| Jun 30, 2013 | -668,000.00 |
| Mar 31, 2013 | -553,000.00 |
| Dec 31, 2012 | -651,749.49 |
| Sep 30, 2012 | -471,000.00 |
| Jun 30, 2012 | -344,000.00 |
| Mar 31, 2012 | -283,000.00 |
| Dec 31, 2011 | 228,000.00 |
| Sep 30, 2011 | -246,000.00 |
| Jun 30, 2011 | -334,000.00 |
| Mar 31, 2011 | -409,000.00 |
API Access
Xtl Biopharmaceuticals Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();